The FIP1L1-PDGFRA syndrome: a case of mistaken identity?

被引：3

作者：

Apperley, J ^{[1
]}

Bain, B ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England

来源：

BLOOD | 2004年 / 104卷 / 10期

关键词：

D O I：

10.1182/blood-2004-08-3310

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The diagnosis of hypereosinophilic syndrome (HES) has been largely a process of exclusion and by definition therefore, unsatisfactory. Frustrated hematologists were comforted by the knowledge that a better understanding of the molecular pathogenesis would eventually resolve their difficulties. This better understanding is now beginning to emerge.

引用

页码：2999 / 3000

页数：2

共 4 条

[1] A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [J].

Cools, J ;

DeAngelo, DJ ;

Gotlib, J ;

Stover, EH ;

Legare, RD ;

Cortes, J ;

Kutok, J ;

Clark, J ;

Galinsky, I ;

Griffin, JD ;

Cross, NCP ;

Tefferi, A ;

Malone, J ;

Alam, R ;

Schrier, SL ;

Schmid, J ;

Rose, M ;

Vandenberghe, P ;

Verhoef, G ;

Boogaerts, M ;

Wlodarska, I ;

Kantarjian, H ;

Marynen, P ;

Coutre, SE ;

Stone, R ;

Gilliland, DG .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (13) :1201-1214

[2]

Jaffe E.S., 2001, PATHOLOGY GENETICS T, V3

[3] Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness [J].

Klion, AD ;

Noel, P ;

Akin, C ;

Law, MA ;

Gilliland, DG ;

Cools, J ;

Metcalfe, DD ;

Nutman, TB .

BLOOD, 2003, 101 (12) :4660-4666

[4] Imatinib for systemic mast-cell disease [J].

Pardanani, A ;

Elliott, M ;

Reeder, T ;

Li, CY ;

Baxter, EJ ;

Cross, NCP ;

Tefferi, A .

LANCET, 2003, 362 (9383) :535-537

← 1 →